教員情報 - 方　軍

ファン　ジュン Fang Jun
方　軍

所属薬学部薬学科

職種准教授

学会発表
1.	2001/07/13	Preparation of poly(ethylene glycol) conjugated D-amino acid oxidase and its antitumor activity based on tumor-targeted delivery and generation of hydrogen peroxide (Intl. Symposium on Polymer Therapeutics)
2.	2002/09/23	Pegylated zinc protoporphyrin for cancer therapy: an antitumor strategy by targeted inhibition of heme oxygenase-1 in solid tumor (2nd Intl. Symposium & Exposition on Tumor Targeted Delivery System (CRS/NCI))
3.	2003/07/20	Oxidation Chemotherapy via Targeted Delivery of Pegylated D-Amino Acid Oxidase and Pegylated Zinc Protoprophyrin Based on EPR Effect (30th Annual Meeting and Exposition of Controlled Release Society)
4.	2004/03/27	The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential target in neuroblastoma (95th Annual Meeting of the American Association for Cancer Research)
5.	2004/11/08	The H+-linked monocarboxylate transporter (MCT1/SLC16A1): A potential target in neuroblastoma (International Conference on Tumor progression and Therapeutic Resistance)
6.	2006/07/22	Copoly(styrene-maleic acid)-Zinc protoporphyrin: a potent antitumor agent via targeted inhibition of heme oxygenase in solid tumor (33rd Annual Meeting & Exposition of the Controlled Release Society)
7.	2007/03/15	Oxidation dependent anticancer therapy via targeted induction of oxystress in solid tumor (The 1st Sojo Frontier Seminar in Pharmaceutical Sciences)
8.	2007/07/11	Oxystress induced antitumor therapeutics via tumor-targeted delivery of PEG-conjugated D-amino acid oxidase (34th Annual Meeting & Exposition of the Controlled Release Society)
9.	2008/06/12	Oxystress induced antitumor therapy using hydrogen peroxide generated by tumor-targeted delivery of PEG-conjugated D-amino acid oxidase (BIT World Cancer Congress 2008)
10.	2008/10/03	Oxystress-induced antitumor therapeutics via targeted-inhibiting heme oxygenase 1 (HSP32) in tumor (Ehrlich II 2nd World Conference on Magic Bullets)
11.	2009/07/18	SMA-copolymer conjugates of AHPP: a polymeric inhibitor of xanthine oxidase with therapeutic potentials against hypertension (The 36th Annual Meeting and Exposition of the Controlled Release Society)
12.	2010/07/10	Pegylated hemin, a water-soluble micelle with therapeutic potential against ischemia-reperfurion injury via induction of heme oxygenase-1 (The 37th Annual Meeting and Exposition of the Controlled Release Society)
13.	2011/07/30	Augmentation of EPR effect by heme oxygenase-1 (HO-1) (The 38th Annual Meeting and Exposition of the Controlled Release Society)
14.	2012/05/20	Protection of inflammatory bowel diseases and colitis-associated carcinogenesis with 4-vinyl-2,6-dimethoxyphenol (canolol) via suppressing oxidative stress (Keystone Symposia 2012 in Dublin)
15.	2012/07/15	Water soluble polymeric xanthine oxidase inhibitor, PEG-AHPP micelles, as a novel therapeutic for ROS related inflammatory bowel diseases (The 39th Annual Meeting and Exposition of the Controlled Release Society)
16.	2013/03/19	Water-soluble polymeric xanthine oxidase inhibitors as a novel therapeutic for ROS related inflammatory diseases (ICBS2013 in Tsukuba)
17.	2013/07/21	Preparation of a water soluble carbon monoxide donor, SMA-CORM2 micelles, and therapeutic potential for inflammatory bowel diseases (The 40th Annual Meeting and Exposition of the Controlled Release Society)
18.	2014/05/19	Micelles of CO releasing molecules encapsulated by styrene-maleic acid copolymer, exhibit therapeutic potential for inflammatory bowel disease with disease-targeting property by EPR effect. (10th International Symposium on Polymer Therapeutics: From laboratory to Clinical Practice)
19.	2014/07/30	細菌による抗癌治療：EPR効果による細菌の腫瘍へのデリバリーとその増強法 (第３０回日本DDS学会)
20.	2014/09/25	Upregulation of HO-1 in colorectal cancer with increased circulation CO levels, potentially affects chemosensitivity (73th Annual Meeting of the Japanese Cancer Association)
21.	2015/07/02	腫瘍標的型亜鉛プロトポルフィリンP-HPMAミセルを用いる癌光化学治療とイメジング (第３１回日本DDS学会)
22.	2015/07/26	Styrene-maleic acid copolymer conjugated pirarubicin, an anticancer nanomedicine with good stability and tumor-targeting property (The 42th Annual Meeting and Exposition of the Controlled Release Society)
23.	2015/11/02	Photodynamic therapy and imaging based on tumor-targeted nanoprobe, pHPMA-conjugated zinc protoporphyrin, and its augmentation (International conference on Clinical Sciences and Drug Discovery (CDDD-2015))
24.	2015/11/23	Photodynamic therapy and imaging based on tumor-targeted nanoprobe, pHPMA-conjugated zinc protoporphyrin, and its augmentation. (Symposium of 30 Years Anniversary of the EPR Effect: Revolution in Tumor Drug Delivery using Nanomedicine.)
25.	2015/11/30	Upregulation of HO-1 in colorectal cancer with increased circulation CO levels, potentially affects chemosensitivity. (The 20th Japan-Korea Cancer Research Workshop)
26.	2016/05/20	Water soluble PEG-conjugate of xanthine oxidase inhibitor, PEG-AHPP micelles, as a novel therapeutic for ROS related inflammatory bowel diseases. (The 9th International Conference on the Biology, Chemistry, and Therapeutic Applications of Nitric Oxide)
27.	2016/05/23	Photodynamic therapy and imaging based on tumor-targeted nanoprobe, pHPMA-conjugated zinc protoporphyrin, and its augmentation (11th International Symposium on Polymers Therapeutics From Laboratory to Clinical Practice.)
28.	2016/06/30	In vivo evaluation and comparison of P-HPMA-pirarubicin conjugates with different molecular weights (32nd Annual Meeting of the Japan Society of Drug Delivery System)
29.	2016/09/07	Photodynamic therapy and imaging based on tumor-targeted nanoprobe, pHPMA-conjugated zinc protoporphyrin, and its augmentation. (International Conference on Pharmaceutical Chemistry)
30.	2016/10/06	In vivo evaluation and comparison of P-HPMA-pirarubicin conjugates with different molecular weights (75th Annual Meeting of the Japanese Cancer Association)
31.	2017/07/06	Investigation the effect of NO donor on enhancing EPR effect (33rd Annual Meeting of the Japan Society of Drug Delivery System.)
32.	2017/07/16	Augmentation of tumor-targeted photodynamic therapy and imaging by modulating tumor microenvironment using nitric oxide generating agents (The 44th Annual Meeting and Exposition of the Controlled Release Society)
33.	2018/06/21	Development of HPMA polymer conjugated phropheophorbide-a as a cancer theranostic probe (34th Annual Meeting of the Japan Society of Drug Delivery System.)
34.	2018/08/20	N-(2-Hydroxypropyl)methacrylamide polymer conjugated pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging (International Conference on Medicinal Chemistry & Drug Design)
35.	2018/09/27	Polymeric pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging. (77th Annual Meeting of the Japanese Cancer Association)
36.	2019/06/27	Improving therapeutic effect of nanomedicine by EPR enhancers. (83th Prague Meeting on Macromolecules.)
37.	2019/07/05	Augmentation of EPR effect by using carbon monoxide generators. (35th Annual Meeting of the Japan Society of Drug Delivery System.)
38.	2019/07/23	Polymeric pyropheophorbide-a, a promising tumor-targeted theranostic probe for photodynamic therapy and imaging. (The 46th Annual Meeting and Exposition of the Controlled Release Society)
39.	2019/09/27	Augmentation of EPR effect and therapeutic efficacy of nanomedicine by carbon monoxide generating agents. (78th Annual Meeting of the Japanese Cancer Association)